The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
| Title | Creator | Relation Is Part Of | ||
|---|---|---|---|---|
| 226 |
 |
Use Of Wide-Field Retinography For Periphlebitis Detection In Patients With Multiple Sclerosis | Ruben Torres-Torres; Elena Fraga-Pumar; Pablo Villoslada; Bernardo F. Sanchez-Dalmau | NANOS 2015: Poster Presentations |
| 227 |
 |
Uveo-Retinal Encephalities Syndromes | Roy W. Beck | NANOS 1988: Retina in Neuro-Ophthalmology Symposium |
| 228 |
 |
The Value of Magnetic Resonance Imaging in Possible or Probable Multiple Sclerosis | Robert L. Rodnitzky | MRI vs. All Other Modalities in the Diagnosis of Multiple Sclerosis Symposium |
| 229 |
 |
Vision-Related Quality of Life in Multiple Sclerosis | Laura J. Balcer; Monika L. Baier; Amy M. Kunkle; Richard A. Rudick; Bianca Weinstock-Guttman; Gary R. Cutter; Maureen G. Maguire | NANOS 2000: Poster Presentations |
| 230 |
 |
Visual Dysfunction in MS Is Associated with Abnormalities in Normal-Appearing Gray and White Matter | Laura J. Balcer; Gregory F. Wu; Jayaram K. Udupa; Tianhu Lei; Tad Iwanaga; Eric D. Schwartz; Lisa M. Desiderio; M. Ligia Nano-Schiavi; Steven L. Galetta; Maureen G. Maguire; Gary R. Cutter | |
| 231 |
 |
Visual Field Profile of Optic Neuritis: A Final Follow-Up Report from the Optic Neuritis Treatment Trial (ONTT) from Baseline to 15 Years | John L. Keltner, MD; Chris A. Johnson, MD; Kimberly Cello; Robin Gal; Roy Beck | NANOS 2010: Scientific Platform Presentations |
| 232 |
 |
Visual Field Profile of Optic Neuritis: A Final Follow-Up Report from the Optic Neuritis Treatment Trial (ONTT) from Baseline to 15 Years | John L. Keltner, MD; Chris A. Johnson, MD; Kimberly Cello; Robin Gal; Roy Beck | NANOS 2010: Scientific Platform Presentations |
| 233 |
 |
Visual Function and Disease Phenotype in Multiple Sclerosis | Gregory F. Wu, MD, PhD; M. Ligia Nano-Schiavi, CO; Steven L. Galetta, MD; Jeffrey A. Cohen, MD; Laura J. Balcer, MD, MSCE | NANOS 2004: Scientific Platform Presentations (Session 2) |
| 234 |
 |
Visual Function and Freedom from Disease Activity in a Phase 3 Trial for Relapsing Multiple Sclerosis | Laura J. Balcer; Steven L. Galetta; Annie Zhang; Ryan Arnold | NANOS 2013: Poster Presentations |
| 235 |
 |
Visual function and retinal nerve fiber layer thickness in Neuromyelitis optica: a longitudinal and comparative study | Rabih Hage; Philippe Cabre; Séverine Jeannin; Harold Merle | NANOS 2014: Poster Presentations |
| 236 |
 |
Visual Function at Baseline and One Month in Acute Demyelinating Optic Neuritis Predicts Visual Outcome | Mark Kupersmith; Robin Gal; Roy Beck; Neil Miller; Optic Neuritis Treatment Group | NANOS 2007: Scientific Platform Presentations (Session II) |
| 237 |
 |
Visual Motion Perception Disorders | James A. Sharpe, MD, FRCP(C) (1941-2013) | NANOS 1994: Clinical Presentations (Session I) |
| 238 |
 |
Visual Pathway Axonal Loss in Patients with Benign Multiple Sclerosis | Jennifer Graves; Kristin Galetta; Lauren Talman; Deacon Lile; Stephanie Syc; Amy Conger; Gina Remington; Peter Calabresi; Elliott Frohman; Steven Galetta; Laura Balcer | NANOS 2011: Scientific Platform Presentations (Session II) |